ClinicalTrials.gov
public full text
Public Domain
A Phase 1, First-in-human, Double-blinded, Randomized, Placebo-controlled Trial of a Zika Virus Purified Inactivated Vaccine (ZPIV) With Alum Adjuvant in Healthy Flavivirus-naive and Flavivirus-Primed Subjects.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- 21 U.S.C. § 209 — Poisons; book entry of sale; labels#577478
- Liberation Medicine in Authoritarian Contexts: The Brutality of U.S. Mass Incarceration.#1107452
- Dying to Be Counted: The Social Determinants of Data – A Critical Analysis of the Quality of the 2020 North Carolina Latino COVID-19 Mortality Data#14621
- Advancing Vaccine Equity Through Understanding Vaccine Hesitancy, Barriers, and Trust#885343
- Targeted Killing in U.S. Counterterrorism Strategy and Law#641278
Record · ID 448307
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive